Loading...
Price History
Market Data
| Market Cap | 5.18B |
| P/E Ratio | 34.07 |
| P/B Ratio | 4.12 |
| EPS | 4.75 |
| Dividend Yield | 0.59% |
| D/E Ratio | 0.34 |
| Current Ratio | 2.07 |
| Currency | USD |
Key Financial Metrics
1.04B
Revenue
154.84M
Net Income
4.75
EPS (Diluted)
336.72M
Free Cash Flow
Profitability
Gross Margin
35.7%
Operating Margin
20.2%
Net Profit Margin
14.9%
EBITDA
266.03M
Returns & Efficiency
Return on Assets (ROA)
9.2%
Return on Equity (ROE)
12.3%
Dividend Yield
0.59%
EPS
4.75
Financial Health
Total Assets
1.69B
Total Debt
-
Debt to Equity
0.34x
Current Ratio
2.07
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | MONTVALE, NJ |
| Fiscal Year | 2025 |
Peers
13.26B
P/E: 50.4
4.97B
P/E: --
4.97B
P/E: --
CHEMOURS CO
CC
4.19B
P/E: --
OLIN CORP
OLN
3.28B
P/E: --
OLIN Corp
OLN
3.28B
P/E: --
INGEVITY CORP
NGVT
2.71B
P/E: --
HUNTSMAN CORP
HUN
2.62B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$5.18B
P/E Ratio (TTM)34.1
Price to Book4.12
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin35.7%
Operating Margin20.2%
Net Margin14.9%
ROE12.3%
ROA9.2%
Leverage & Liquidity
Debt to Equity0.34
Current Ratio2.07
Total Debt-
Total Assets$1.69B
Stockholders' Equity$1.26B
Income Statement (FY 2025)
Revenue$1.04B
Gross Profit$370.63M
Operating Income$209.33M
Net Income$154.84M
EPS (Diluted)$4.75
Cash Flow (FY 2025)
Free Cash Flow$336.72M
Cash & Equivalents$74.57M
Revenue Growth8.8%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 5 PARAGON DRIVE MONTVALE, NJ 07645 |
| Phone | N/A |
| Incorporated | MD, US |
| EIN | 132578432 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 32.03M |
| Stockholders' Equity | $1.26B |
| Cash & Equivalents | $74.57M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-30
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-30
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-28
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-27
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-27
Local
3
Initial Ownership Report
Initial statement of beneficial ownership of securities
Filed: 2026-04-07
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-20
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-13
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-13
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-13
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-13
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-13
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-13
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | BALCHEM CORP |
| Ticker | BCPC |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | MONTVALE, NJ |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 5.18B |
| Revenue | 1.04B |
| Net Income | 154.84M |
| P/E Ratio | 34.07 |
| EPS | 4.75 |
| Net Margin | 14.9% |
| ROE | 12.3% |
| Dividend Yield | 0.59% |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...